Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4216119 | Revue des Maladies Respiratoires Actualités | 2011 | 7 Pages |
Abstract
Although no targeted agent has been yet approved for MPM or SCLC treatment, a few clinical trials reported encouraging results and some phase III studies are ongoing. Therefore, clinical and translational research efforts must continue.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
L. Greillier,